BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
12.55
-0.43 (-3.31%)
At close: Jan 29, 2026, 4:00 PM EST
12.50
-0.05 (-0.40%)
After-hours: Jan 29, 2026, 4:10 PM EST
BBOT Market Cap
BBOT has a market cap or net worth of $999.86 million as of January 29, 2026. Its market cap has increased by 306.99% in one year.
Market Cap
999.86M
Enterprise Value
534.46M
1-Year Change
306.99%
Ranking
Category
Stock Price
$12.55
Market Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $999.86M, an increase of 2,516.57%. That is a compound annual growth rate of 424.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 1.04B | 3.67% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 1.04B |
| Nanobiotix | 1.04B |
| Aktis Oncology | 1.03B |
| ARS Pharmaceuticals | 1.01B |
| GH Research | 1.01B |
| Ventyx Biosciences | 1.00B |
| CytomX Therapeutics | 972.56M |
| Theravance Biopharma | 971.90M |